Patent Law Weblog
recent posts
- Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. (2026)
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
about
Month: June 2010
-
By Donald Zuhn — Last week, Representative Dennis Kucinich (D-OH) (at right) introduced three bills in the House related to the labeling of food containing genetically engineered material, the cultivation and handling of genetically engineered crops, and the establishment of a set of farmer rights regarding genetically engineered animals, plants, and seeds: • The…
-
By Donald Zuhn — The Supreme Court waited until the eleventh hour to issue its long-awaited decision in Bilski v. Kappos, affirming the Federal Circuit's determination that an application directed to hedging risk in energy commodities was not patent eligible while determining that the Federal Circuit's machine-or-transformation test is not the sole test for…
-
By Sarah Fendrick — The U.S. Patent and Trademark Office announced in a notice published in the Federal Register (75 Fed. Reg. 33584) that it is considering changes to restriction practice aimed at improving the quality and consistency of restriction requirements made by Office personnel. The USPTO has begun to solicit public comment regarding…
-
By Kevin E. Noonan — The Supreme Court decided Bilski v. Kappos today and, as anticipated, agreed with the Federal Circuit that Bilski's claims to methods for "hedging" risk in commodities trading are not patent-eligible subject matter. After that, the opinion elevates the analysis to nothing short of advanced tea-leaf reading (including ample evidence…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. AstraZeneca Pharmaceuticals LP et al. v. Glenmark Generics Inc. USA1:10-cv-00543; filed June 21, 2010 in the District Court of Delaware • Plaintiffs: AstraZeneca Pharmaceuticals LP; AstraZeneca UK Ltd.; IPR Pharmaceuticals Inc.; Shionogi Seiyaku Kabushiki…
-
June 28-30, 2010 – 3rd Annual Product and Pipeline Enhancement for Generics (marcus evans) – Washington, DC June 29, 2010 – Navigating the U.S. Biosimilar Pathway (American Bar Association) – 1:00 – 2:30 PM (EST) June 30, 2009 – Markman Hearings and Claim Construction in Patent Litigation 2010 (Practising Law Institute) – New York, NY…
-
American Conference Institute (ACI) will be holding the next session of its FDA Boot Camp conference on August 25-26, 2010 in San Francisco, CA. ACI faculty will help attendees: • Master the complexities of pharmaceutical iP and the regulatory balance between brand name and generic products;• Analyze the future of follow-on biologics following recent health…
-
Technology Transfer Tactics will be offering an audioconference entitled "Protect Your Patents from Inequitable Conduct Charges" on July 22, 2010 from 1:00 – 2:30 PM (EDT). Jack Cook of Quarles & Brady and Stephanie Whitehorse of the Wisconsin Alumni Research Foundation (WARF) will examine both pre-filing issues and post-filing procedures, and provide a detailed blueprint…
-
The American Bar Association (ABA) will be holding its 2010 Annual Meeting from August 5-10 in San Francisco, CA. During the Annual Meeting, various ABA sections and divisions will be offering more than 250 CLE programs, including the following programs that will be offered by the Intellectual Property Law section: • IP Counsel “Pow-Wow” –…
-
Practising Law Institute (PLI) will be holding a two-day seminar entitled: "Advanced Patent Prosecution Workshop 2010: Claim Drafting & Amendment Writing" on July 26-27, 2010 in New York, NY and on August 16-17, 2010 in San Francisco, CA. At the New York seminar, PLI's faculty will offer presentations on the following topics: • Ethics in…
Patent Docs 